Why do patients with cardiac amyloidosis often have low voltage QRS (electrocardiogram) complexes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Cardiac Amyloidosis Causes Low Voltage QRS Complexes

Low voltage QRS complexes occur in cardiac amyloidosis because extracellular amyloid protein deposits in the myocardial interstitium physically disrupt normal electrical conduction through the myocardium, reducing the amplitude of electrical signals despite paradoxically increased ventricular wall thickness. 1

Pathophysiological Mechanism

The fundamental explanation lies in the infiltrative nature of the disease:

  • Amyloid fibrils deposit in the extracellular space between myocytes, creating a non-conductive barrier that interrupts normal electrical signal propagation through the heart muscle 2, 3

  • These protein deposits act as electrical insulators, preventing the normal transmission of depolarization waves across the myocardium, which reduces the voltage amplitude recorded on surface ECG 4

  • The amyloid infiltration causes direct myocyte damage through oxidative stress and mechanical disruption, further impairing the generation and conduction of electrical impulses 2

  • Despite causing ventricular wall thickening (which would normally increase QRS voltage), the non-conductive amyloid material paradoxically reduces electrical signal amplitude 1

The Classic Diagnostic Discordance

This creates the pathognomonic finding that should trigger suspicion for cardiac amyloidosis:

  • Low QRS voltage in limb leads occurs in approximately 50% of patients with cardiac amyloidosis 2

  • This appears paradoxical when echocardiography shows increased left ventricular wall thickness (≥14 mm), creating a voltage-to-mass discordance 1

  • This discordance between wall thickness on echocardiogram and QRS voltage on ECG is specifically highlighted in the 2022 AHA/ACC/HFSA guidelines as a key diagnostic clue that should prompt evaluation for cardiac amyloidosis 1

Additional ECG Manifestations

Beyond low voltage, the amyloid infiltration causes other characteristic ECG abnormalities:

  • Pseudo-infarction patterns appear in precordial leads due to loss of anterior forces from septal infiltration 2, 4

  • Conduction abnormalities including atrioventricular blocks and sinus node dysfunction result from amyloid deposition in the conduction system 2, 4, 5

  • Atrial fibrillation occurs in up to 70% of patients at diagnosis due to atrial infiltration and stretch 5

Clinical Pitfall to Avoid

Do not dismiss the possibility of cardiac amyloidosis simply because QRS voltage appears normal or even high in some leads. 2 While low voltage in limb leads is common (50% of cases), it is not universal. The diagnosis requires integrating multiple findings including:

  • Clinical context (heart failure symptoms, carpal tunnel syndrome, spinal stenosis, polyneuropathy) 1
  • Echocardiographic features (increased wall thickness, apical sparing pattern) 1
  • Laboratory markers (elevated BNP/NT-proBNP, troponin) 1
  • Advanced imaging (late gadolinium enhancement on cardiac MRI, positive Tc-99m PYP scan) 1, 6

The low voltage QRS is a supportive finding that increases diagnostic suspicion but does not confirm or exclude the diagnosis by itself 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amiloidosis Cardíaca

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.